Fisher Drug Discovery Resource Center
Our vision is to become a leading hub for early-stage drug discovery, empowering the next generation of scientists to drive therapeutic innovation. By combining rigorous scientific training with cutting-edge resources, we aim to remove barriers to discovery, streamline research processes, and foster breakthroughs that contribute to the development of novel treatments. Through collaboration, state-of-the-art technologies, and a commitment to scientific excellence, we seek to make a lasting impact on the future of drug discovery.
Our center is dedicated to training the next generation of drug discovery scientists through immersive, hands-on research focused on the early stages of drug development. By integrating fundamental medical science with practical experience, we equip trainees with the expertise to identify and optimize compounds that precisely target molecular pathways. Our center emphasizes key early discovery processes—from hit identification to lead optimization—fostering a deep molecular understanding of the mechanisms of action of drugs.
To support this mission, we provide access to a diverse collection of 635,000 drug-like compounds, cutting-edge lab automation, and state-of-the-art bioassay technologies. Our advanced instrumentation and expertise in drug-target interactions enable researchers to refine bioassays, identify promising compounds, and optimize early-stage drug candidates efficiently.
Through scientific innovation, impactful publications, and global collaboration, the DDRC strives to accelerate early drug discovery and contribute to the advancement of new therapeutic solutions
(RRID:SCR_020985)
The DDRC supports investigations in the following areas:
-
- developing assay cascades for drug discovery projects
- miniaturized assay development
- high-throughput screening
- identifying compounds for drug discovery or biomedical research
- measuring the kinetics and thermodynamics of biomolecular interactions
Fisher Drug Discovery Resource Center Lecture, June 5, 2024
